Renaissance Technologies - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$238
-36.9%
273,289
-18.8%
0.00%
-100.0%
Q2 2023$377
-21.1%
336,689
-26.7%
0.00%0.0%
Q1 2023$478
-27.4%
459,389
-21.8%
0.00%0.0%
Q4 2022$658
-99.9%
587,392
-10.8%
0.00%0.0%
Q3 2022$744,000
-37.3%
658,489
-18.5%
0.00%0.0%
Q2 2022$1,187,000
-40.1%
807,789
-6.6%
0.00%
-50.0%
Q1 2022$1,981,000
+67.9%
864,951
+101.5%
0.00%
+100.0%
Q4 2021$1,180,000
+93.8%
429,217
+322.9%
0.00%0.0%
Q3 2021$609,000
+77.0%
101,489
+43.8%
0.00%
Q2 2021$344,000
-75.3%
70,589
-87.5%
0.00%
-100.0%
Q1 2021$1,394,000
+10.7%
564,499
+22.9%
0.00%
+100.0%
Q4 2020$1,259,000
+54.5%
459,389
-13.2%
0.00%0.0%
Q3 2020$815,000
-46.6%
528,989
-34.8%
0.00%0.0%
Q2 2020$1,526,000
+128.4%
811,438
+106.5%
0.00%0.0%
Q1 2020$668,000
+159.9%
392,888
+342.9%
0.00%
Q4 2019$257,000
+594.6%
88,701
+232.0%
0.00%
Q1 2019$37,000
-93.2%
26,717
-94.7%
0.00%
-100.0%
Q4 2018$542,000
+150.9%
506,424
+1342.8%
0.00%
Q3 2018$216,000
-70.5%
35,100
-56.2%
0.00%
-100.0%
Q2 2017$731,000
+21.0%
80,200
+5.4%
0.00%0.0%
Q1 2017$604,00076,1000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders